Matthew Pianko

16PUBLICATIONS
83CO-AUTHORS
Medical bacteriologyPredictive and prognostic markersHaematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Jul 20, 2026
Lenalidomide-Related Diarrhea in Patients with Multiple Myeloma Is Associated with Gut Microbiota Dysbiosis and Disruption of the Bile Acid Pool.

|Jul 12, 2025
Predictors of frontline doublet or triplet regimen initiation in transplant-ineligible newly diagnosed multiple myeloma.

Matthew J Pianko, Niodita Gupta-Werner, Bruno Emond

|Dec 18, 2024
Complement C3d enables cell-mediated immunity capable of distinguishing spontaneously transformed from nontransformed cells.

Jeffrey L Platt, Chong Zhao, Jeffrey Chicca

|Oct 28, 2024
Frailty measures in multiple myeloma: evaluating the impact on outcomes and quality-of-life in clinical trials and real-world practice.

Matthew J Pianko, Hira S Mian, Kelly L Schoenbeck

|Aug 30, 2024
Complement C3d enables protective immunity capable of distinguishing spontaneously transformed from non-transformed cells.

Jeffrey L Platt, Chong Zhao, Jeffrey Chicca

|Jun 16, 2024
Linvoseltamab for Treatment of Relapsed/Refractory Multiple Myeloma.

Naresh Bumma, Joshua Richter, Sundar Jagannath

Pageof 3

Frequent Collaborators

5 joint publications

Alexander M Lesokhin

4 joint publications

Hani Hassoun

3 joint publications

Ola Landgren

3 joint publications

Neha Korde